Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Edgewise Therapeutics, Inc. (EWTX) had Return on Tangible Equity of -7.28% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-40.67M |
|
-- |
|
-- |
|
$46.86M |
|
$-46.86M |
|
$6.19M |
|
$-40.67M |
|
$-40.67M |
|
$-40.67M |
|
$-40.67M |
|
$-40.67M |
|
$-40.67M |
|
$-46.86M |
|
$-48.34M |
|
105.49M |
|
105.49M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$573.90M |
|
$8.13M |
|
$9.57M |
|
$583.47M |
|
$21.65M |
|
-- |
|
$3.17M |
|
$24.82M |
|
$558.65M |
|
$558.65M |
|
$558.65M |
|
105.76M |
|
| Cash Flow Statement Financials | |
$-105.22M |
|
$-82.55M |
|
$192.11M |
|
$41.67M |
|
$46.00M |
|
$4.34M |
|
$24.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-105.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.28% |
|
|
Return on Tangible Equity |
-7.28% |
-6.97% |
|
-7.28% |
|
$5.28 |
|
$-1.00 |
|
$-1.00 |
|